Non-invasive device for synchronizing chest compression and ventilation parameters to residual myocardial activity during cardiopulmonary resuscitation

• US 7,645,247 B2
• Filed: 10/25/2004
• Issued: 01/12/2010
• Est. Priority Date: 10/25/2004
• Status: Active Grant

• Current Assignee: Zoll Medical Corporation (Asahi Kasei Corporation)
• Original Assignee: Norman A. Paradis
• Inventors: Paradis, Norman A.
• Primary Examiner(s): DEMILLE, DANTON D
• Application Number:
  US10/973,775
• Publication Number:
  US 20060089574A1
• Time in Patent Office: 1,905 Days
• Field of Search: 601 41- 44, 601/107, 601/108, 601148-152, 601/DIG.9, 607/3
• US Class Current: 601/41
• CPC Class Codes: A61H 2031/001 fixed on the chest by suction
• CPC Class Codes: A61H 2201/5007 computer controlled
• CPC Class Codes: A61H 2201/5048 Audio interfaces, e.g. voice or music controlled
• CPC Class Codes: A61H 2201/5058 Sensors or detectors
• CPC Class Codes: A61H 2230/04 Heartbeat characteristics, e.g. E.G.C., blood pressure modulation
• CPC Class Codes: A61H 31/005 with feedback for the user
• CPC Class Codes: A61H 31/006 Power driven
• CPC Class Codes: A61H 31/007 Manual driven
• CPC Class Codes: A61M 16/0051 with alarm devices
• CPC Class Codes: A61M 16/024 including calculation means, e.g. using a processor
• CPC Class Codes: A61M 2205/332 Force measuring means
• CPC Class Codes: Y10S 601/09 including biological sensors

Abstract

In one embodiment, a method for improving the cardiac output of a patient who is suffering from pulseless electrical activity or shock and yet still displays some myocardial wall motion comprises sensing myocardial activity to determine the presence of residual left ventricular pump function having a contraction or ejection phase and a filling or relaxation phase. In such cases, a compressive force is repeatedly applied to the chest based on the sensed myocardial activity such that the compressive force is applied during at least some of the ejection phases and is ceased during at least some of the relaxation phases to permit residual cardiac filling, thereby enhancing cardiac output and organ perfusion. Also incorporated may be a logic circuit capable of utilizing multiple sensing modalities and optimizing the synchronization pattern between multiple phasic therapeutic modalities and myocardial residual mechanical function.

Claims

1. A method for improving the cardiac output and clinical outcome of a lifeless patient in apparent cardiac arrest who is suffering from pulseless electrical activity and yet still displays some myocardial wall motion detectable with sensing technology, the method comprising:

detecting and characterizing residual myocardial mechanical activity with a sensing system that senses actual myocardial motion or pulsatile blood flow to determine the presence of residual left ventricular pump function, while the patient has no clinically detectable pulse and is diagnosed as in a state of cardiac arrest;

repeatedly applying at least one phasic therapy based on the sensed myocardial mechanical activity such that the phasic therapy is synchronized with the sensed activity so as to augment cardiac ejection and avoid interfering with cardiac filling, and wherein the phasic therapy comprises applying a compressive force to the chest at least at some point during a time period corresponding to ejection phase and ceasing any compressive force during a relaxation phase.

2. A method as in claim 1, wherein the phasic therapy is at least two phasic therapies which include the compressive force and a second phasic therapy selected from a group consisting of active chest decompression, abdominal compression, ventilation, phasic limb-compression, myocardial electrical stimulation, intravascular fluid shifting, intravascular balloon inflation-deflation, and application of transthoracic electromagnetic irradiation.

3. A method as in claim 1, wherein the compressive force is applied to the patient'"'"'s chest at the sternal or parasternal, or left intercostal areas.

4. A method as in claim 1, wherein the compressive force is applied during each sensed ejection phase.

5. A method as in claim 1, wherein the compressive force is applied only at certain ejection phases.

6. A method as in claim 1, wherein the compressive force is applied for only a certain duration of the ejection phase.

7. A method as in claim 1, wherein the phasic therapy comprises actively lifting or active decompression of the patient'"'"'s chest.

8. A method as in claim 7, wherein the lifting or decompression is applied only at certain relaxation phases of the heart or for a certain duration of the relaxation phases.

9. A method as in claim 1, further comprising applying or altering ventilations based on the sensed myocardial activity such that the change in ventilation enhances cardiac output and patient outcome.

10. A method as in claim 1, wherein the compressive force is applied using equipment selected from a group consisting of mechanical compression devices, inflatable vests, nerve stimulators, and suction based compression-decompression devices.

11. A method as in claim 1, wherein the sensing system includes a sensor in a group consisting sensors of echocardiography, Doppler ultrasonography, plethysmography, and phonocardiography.

12. A method as in claim 1, further comprising displaying the presence of detected myocardial activity.

13. A method as in claim 1, wherein the sensing system that comprises an array of sensors.